Psychedelic Innovation Fund

Learn more about Psychedelic Innovation Fund, its impact, and how to contribute.

Mission

The mission of Psychedelic Innovation Fund (PIF) is to advance the evidence-based use of psychedelic medicines and psychedelic-assisted therapies for mental health and neuroscience disorders. PIF supports: 1) human clinical trials, 2) access for underserved populations, 3) education and training in psychedelic medicine and science, and 4) innovation in creating psychedelic-based care models that are affordable, sustainable, and scalable.

Supported Impact Ventures and Initiatives

In furtherance of its mission, Psychedelic Innovation Fund supports:

Psychedelic Science Institute

At Psychedelic Science Institute (PSI) and our affiliated TRIP Clinics, we believe psychedelic-assisted therapies and medicines have the potential to transform mental health care and neuroscience.

Despite growing public interest and promising early results, rigorous research is still needed to determine which psychedelic compounds, such as psilocybin, LSD, and MDMA, are safe and effective for specific conditions and patient populations. In this rapidly evolving field, where ancient wisdom meets modern science and cultural hype, credibility and clinical experience are more important than ever.

PSI was founded by a team of clinician-scientists with over 30 years of combined experience in psychedelic care and research. In July 2025, we opened our first two TRIP Clinics in Santa Monica and Hollywood, California. These state-of-the-art clinics are designed to safely deliver ketamine-assisted psychotherapy and conduct clinical trials of next-generation psychedelic medicines for conditions such as depression, anxiety, PTSD, and substance use disorders.

We are committed to merging compassionate clinical care with scientific rigor, while creating a trusted, patient-centered space for healing, discovery, and education. Join us in accelerating this paradigm-shifting movement, grounded in evidence and driven by compassion as we aim to:

 

  • Develop safe and effective psychedelic-based therapies
  • Advance the field of psychedelic science
  • Expand access to care for people in need
  • Train the next generation of clinicians and researchers in psychedelic medicine.

Highlights and News

LOHAS is proud to share news and updates spotlighting the impact Psychedelic Innovation Fund is making.

Psychedelic Science Institute Launches Clinical Trial Sites in Los Angeles

Contribute to Psychedelic Innovation Fund

All contributions to the 501(c)(3) nonprofit program are tax-deductible.

LOHAS provides third-party oversight to ensure that all allocations from the nonprofit align with the stated mission.

Grants or distributions accepted from:
Individuals • Corporations • Donor-Advised Funds • Foundations
Retirement Accounts • Charitable Trusts

Donate any asset with established or appraisable value, such as:
Stocks • Bonds • Real Estate • Collectibles • Art
Cryptocurrency • Privately Held Business Interests

To invest directly in a supported impact venture from your Donor-Advised Fund or Foundation,
contact LOHAS for a consultation.

Support the Mission

Psychedelic Innovation Fund accepts cash contributions from individuals and companies; grants and distributions from donor-advised funds, foundations, and charitable trusts; and anything with established or appraisable value, including cryptocurrency, real estate, stocks, bonds, privately held business interests, and collectible art.

Fill out the form to request contribution instructions or ask any questions.